HCW Biologics regains rights to CAR-T therapy reagents from Wugen

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to HCW Biologics regains rights to CAR-T therapy reagents from Wugen
(NASDAQ: HCWB) Delayed: 1.28 -0.04 (3.03%)
Previous Close $1.32    52 Week High $ 
Open $1.31    52 Week Low $ 
Day High $1.33    P/E N/A 
Day Low $1.22    EPS $ 
Volume 532,837